Insights

Sustainable biomanufacturing Provectus Algae offers end-to-end biomanufacturing powered by Precision Photosynthesis to produce high-value biobased chemicals and biologics, presenting a strong opportunity to sell sustainability-focused production capabilities to partners in agriculture, food, cosmetics, and pharmaceuticals.

Fast market access The company emphasizes rapid speed to market through integrated discovery to production platforms, suggesting a compelling value proposition for customers needing rapid development timelines and scalable algae-based solutions.

Strategic partnerships Recent Series A funding and government grant support, plus board additions from notable investors and industry experts, indicate strong validation and potential for co-development or licensing agreements with larger partners and ecosystem players.

Technology stack leverage Advances in automation, machine learning, and synthetic biology underpin Provectus Algae’s capabilities, offering sales angles around optimizing processes, yield, and quality control for prospective customers seeking cutting-edge biomanufacturing efficiency.

Diversified market reach Applications span agriculture, food and beverage, aquaculture, cosmetics, and pharmaceuticals, suggesting cross-vertical opportunities for upsell of integrated algae-derived ingredients and custom bioproducts to multiple industry segments.

Provectus Algae Tech Stack

Provectus Algae uses 8 technology products and services including LiteSpeed Cache, Ansible, Altium, and more. Explore Provectus Algae's tech stack below.

  • LiteSpeed Cache
    Caching
  • Ansible
    Configuration Management
  • Altium
    Dev Tools
  • Microsoft Excel
    Editors
  • jQuery Migrate
    Javascript Libraries
  • Elementor
    Page Builders
  • C++
    Programming Languages
  • Google Tag Manager
    Tag Management

Media & News

Provectus Algae's Email Address Formats

Provectus Algae uses at least 1 format(s):
Provectus Algae Email FormatsExamplePercentage
First@provectusalgae.comJohn@provectusalgae.com
52%
First.Last@provectusalgae.comJohn.Doe@provectusalgae.com
25%
First.L@provectusalgae.comJohn.D@provectusalgae.com
23%

Frequently Asked Questions

What is Provectus Algae's official website and social media links?

Minus sign iconPlus sign icon
Provectus Algae's official website is provectusalgae.com and has social profiles on LinkedInCrunchbase.

How much revenue does Provectus Algae generate?

Minus sign iconPlus sign icon
As of July 2026, Provectus Algae's annual revenue is estimated to be $1M - $10M.

What is Provectus Algae's SIC code NAICS code?

Minus sign iconPlus sign icon
Provectus Algae's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Provectus Algae have currently?

Minus sign iconPlus sign icon
As of July 2026, Provectus Algae has approximately 27 employees across 3 continents, including OceaniaAsiaNorth America. Key team members include Cto Provectus Algae: P. T.Head Of Design Engineering: O. J. B.Founder & Ceo: N. S.. Explore Provectus Algae's employee directory with LeadIQ.

What industry does Provectus Algae belong to?

Minus sign iconPlus sign icon
Provectus Algae operates in the Biotechnology Research industry.

What technology does Provectus Algae use?

Minus sign iconPlus sign icon
Provectus Algae's tech stack includes LiteSpeed CacheAnsibleAltiumMicrosoft ExceljQuery MigrateElementorC++Google Tag Manager.

What is Provectus Algae's email format?

Minus sign iconPlus sign icon
Provectus Algae's email format typically follows the pattern of First@provectusalgae.com. Find more Provectus Algae email formats with LeadIQ.

How much funding has Provectus Algae raised to date?

Minus sign iconPlus sign icon
As of July 2026, Provectus Algae has raised $30M in funding. The last funding round occurred on Jul 30, 2025 for $2.6M.

When was Provectus Algae founded?

Minus sign iconPlus sign icon
Provectus Algae was founded in 2018.
Provectus Algae logo

Provectus Algae

Biotechnology ResearchWestern Australia, Australia11-50 Employees

Provectus Algae is a biotechnology company focused on optimizing algae and microalgae to produce high-value biobased chemicals, specialty ingredients, and biologics. It uses photosynthetic processes to convert light and carbon dioxide into these bioproducts, supported by an end-to-end biomanufacturing platform. The platform, built around Precision Photosynthesis technology, combines automation, machine learning, and synthetic biology to move from discovery to scalable production. 

The company serves partners across industries including agriculture, food and beverage, aquaculture, cosmetics and personal care, and pharmaceuticals, offering sustainable and scalable algae-derived products. Based in Western Australia, Australia, Provectus Algae is a small-to-mid sized team focused on rapid development and licensing of biomanufacturing processes for its commercial partners; in July 2025, it appointed Tom Chi to its board of directors as a notable leadership update.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $30M

    Provectus Algae has raised a total of $30M of funding over 6 rounds. Their latest funding round was raised on Jul 30, 2025 in the amount of $2.6Mas a grant.

  • $1M - $10M

    Provectus Algae's revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $30M

    Provectus Algae has raised a total of $30M of funding over 6 rounds. Their latest funding round was raised on Jul 30, 2025 in the amount of $2.6Mas a grant.

  • $1M - $10M

    Provectus Algae's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.